According to what Dog is cutting the FDA employees (FDA), the investigation of Neuralink

The cleansing of federal employees implemented by the Ministry of Governmental efficiency (DOGE) somehow keeps the employees participating in the investigation of Elon Musk companies. According to Reuters reportMany American Food and Drug Administration employees who were assigned to manage reviews and applications related to Musk’s Neuralink receiving pink slips during the weekend.

For every Reuters20 people who worked in the FDA nervous and emotional medicine office as part of a wider voltage being implemented by DOGE to reduce the federal workforce. Many of these employees worked directly on Neuralink, Musk, which produces the stroke facades designed to be planted in a human brain, and was tasked with reviewing clinical trial applications.

While the sources that Reuters spoke to said they did not believe that these employees were specifically targeted, limiting workers within the medical devices office will not make things easier for companies such as Neuralink, which is likely to see the approval process fast. Less people to agree to applications means either the process slows down more or the corners are cut. Guess any options of these options prefer to musk.

The target or not, it is worth noting the frequency of the persons involved in organizing the companies owned by the demobilization operations that it started. According to A report from the New York TimesAt least 11 federal agencies targeted by the Doge Cuts have continuous procedures related to Musk Companies – a total of 32 investigations, complaints, and enforcement procedures that appear to either be ground to stop or disappear as a result of the reduction of employees.

Neuralink appears to have benefited from the efforts made to a monitoring disk. Last month, the Inspector General should be in the US Department of Agriculture She was removed from her office in safety After refusing to comply with her end, which I believed was illegal. Certain to be He is heading to an investigation in Neuralink Given whether the company violates animal care rules related to its tests on animal themes.

Food and drug administration (FDA), too, is looking at similar issues. Last year, the agency found that Neuralink animal laboratories participated in it.Conditions or practices are rejectedHe urged the company to address cases – but no punitive procedures related to the investigation have been issued.

Neuralink and FDA also had a confrontation about allowing the company to move forward in human experiences, which is a request The Food and Drug Administration refused due to safety risks In 2022, he finally allowed limited experiences Moving forward after a year. In 2024, FDA gave her neuralink to her Appointment of a “penetration device”Which allows a faster review process. The only thing that may not be any review at all.